Since the observed positive stimulating effect of EPO/EPOR on the haematopoiesis, the production of recombinant human EPO (rhEPO) was initiated by pharmaceutical companies and subsequently it was approved for anaemia treatment. This evidence concerns the gene EPO and anemia.